Physician profile
Mark W Morrison
NPI 1588698443
$2,765.27
in general payments reported to CMS, 2019-2025
29 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $166 · 2021: $461 · 2022: $608 · 2023: $680 · 2024: $112 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $687.72 | 2019-2023 | |
| Minerva Surgical, INC | $215.95 | 2022-2023 | |
| Pfizer INC. | $183.53 | 2019-2025 | |
| Aspira Women'S Health INC | $181.67 | 2022 | |
| Myovant Sciences INC. | $180.15 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $147.78 | 2023-2024 | Myfembree |
| Agile Therapeutics, INC. | $123.00 | 2021-2024 | Twirla |
| Mayne Pharma Commercial LLC | $120.94 | 2023-2025 | |
| Hologic Sales and Service, LLC | $116.46 | 2022-2024 | Myosure Tissue Removal Device, Coolseal Generator, Acessa Provu System |
| Roche Diagnostics Corporation | $115.77 | 2019 | |
| Therapeuticsmd, INC. | $112.96 | 2019-2021 | |
| Astellas Pharma US INC | $108.87 | 2020-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $90.47 | 2019-2023 | |
| Avion Pharmaceuticals | $59.04 | 2019-2022 | |
| Organon LLC | $35.86 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $35.29 | 2023 | Paragard T 380a, Wallach Cryosurgical Equipment |
| Biogen, INC. | $34.25 | 2025 | Zurzuvae |
| Duchesnay USA Incorporated | $30.50 | 2019 | |
| Exeltis, USA INC. | $28.70 | 2022-2023 | Slynd |
| Dexcom, INC. | $25.30 | 2025 | Dexcom G6 Transmitter |
| Gynesonics, INC. | $22.58 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Davol INC. | $16.95 | 2023 | Arista Ah Flexitip |
| Ascend Therapeutics US, LLC | $15.35 | 2021 | |
| Scynexis, INC. | $14.85 | 2022 | |
| Dysis Medical, INC. | $13.76 | 2020 | |
| Allergan, INC. | $12.63 | 2019 | |
| Merck Sharp & Dohme LLC | $11.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.63 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.